Cross-sectional Study of Resident Physician Knowledge and Perceptions Regarding MASLD in Canada [0.03%]
加拿大住院医师关于MASLD的知识和认知的横断面研究
Kai Zhu,Manisha Jogendran,Yanru Zhang et al.
Kai Zhu et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of Canadians. As its prevalence grows, it is crucial for future primary care physicians to have a thorough understandi...
Commentary on Kehar et al [0.03%]
对Kehar等人的评论
Huzafa Ali,Munaiba Ahmad,Mahfuja Jahan Ima
Huzafa Ali
Prevalence and Predicting Factors of Caregiver Burden in Cirrhotic Patients [0.03%]
肝硬化患者照护负担的流行病学特征及其影响因素分析
Carmen Ching,Nicole Wiebe,Julie Zhu
Carmen Ching
Background: Cirrhosis is a major cause of morbidity and mortality. Caregivers of cirrhotic patients provide significant support related to disease manifestations and complications. This scoping review aims to identify the...
Validation of FIB-4 for the Diagnosis of Liver Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease [0.03%]
FIB-4在代谢功能障碍相关肝脂肪变性肝病中诊断肝硬化的验证研究
Chinmay Bera,Nashla Hamdan-Perez,Heather Mary-Kathleen Kosick et al.
Chinmay Bera et al.
American Association for the Study of Liver Diseases practice guidance on metabolic dysfunction-associated steatotic liver disease (MASLD) has recommended using specific cut-off values for the Fibrosis-4 index (FIB-4) to detect cirrhosis. A...
Christian Vincelette,François Martin Carrier
Christian Vincelette
Arafat Hassan Tariq,Mirha Imran Khan,Waqar Ahmad Alvi
Arafat Hassan Tariq
Predicting Fatal Drug Poisoning Among People Living with HIV-HCV Co-Infection [0.03%]
预测HIV-HCV双重感染者中致命药物中毒的情况
Mélanie Bédard,Erica Em Moodie,Joseph Cox et al.
Mélanie Bédard et al.
Background: Drug poisoning (overdose) is a public health crisis, particularly among people living with HIV and hepatitis C (HCV) co-infection. Identifying potential predictors of drug poisoning could help decrease drug-re...
Vikrant Sood,Mohit Kehar
Vikrant Sood
The Impact of New Direct-Acting Antiviral Therapy on the Prevalence and Undiagnosed Proportion of Chronic Hepatitis C Infection in Alberta: A Model-Based Analysis [0.03%]
新型直接抗病毒疗法对艾伯塔省慢性丙型肝炎感染患病率和未诊断比例的影响：基于模型的分析
Farinaz Forouzannia,Diedron Lewis,Nkiruka Eze et al.
Farinaz Forouzannia et al.
Background: Understanding the impact of wider access to treatment on chronic hepatitis C (CHC) prevalence and the undiagnosed CHC proportion is important to achieving the World Health Organization's 2030 elimination targe...
The Management of Chronic Hepatitis B: 2025 Guidelines Update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada [0.03%]
加拿大肝脏研究协会和加拿大医学微生物学与传染病协会2025年慢性乙型肝炎管理指南更新
Clinical Practice Guidelines Committee Chair;Carla Osiowy;Panel Members;Fernando Alvarez,Carla S Coffin,Curtis L Cooper et al.
Clinical Practice Guidelines Committee Chair;Carla Osiowy;Panel Members;Fernando Alvarez et al.
Chronic hepatitis B virus (HBV) infection poses significant public health challenges in Canada, particularly among newcomers from regions with high HBV prevalence. In alignment with the World Health Organization's goal of HBV elimination by...